Literature DB >> 7579507

At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients.

I Jannink1, J N Bennen, J Blaauw, P J van Diest, J P Baak.   

Abstract

This study compares the influence of two different nuclear sampling methods on the prognostic value of assessments of mean and standard deviation of nuclear area (MNA, SDNA) in 191 consecutive invasive breast cancer patients with long term follow up. The first sampling method used was 'at convenience' sampling (ACS); the second, systematic random sampling (SRS). Both sampling methods were tested with a sample size of 50 nuclei (ACS-50 and SRS-50). To determine whether, besides the sampling methods, sample size had impact on prognostic value as well, the SRS method was also tested using a sample size of 100 nuclei (SRS-100). SDNA values were systematically lower for ACS, obviously due to (unconsciously) not including small and large nuclei. Testing prognostic value of a series of cut off points, MNA and SDNA values assessed by the SRS method were prognostically significantly stronger than the values obtained by the ACS method. This was confirmed in Cox regression analysis. For the MNA, the Mantel-Cox p-values from SRS-50 and SRS-100 measurements were not significantly different. However, for the SDNA, SRS-100 yielded significantly lower p-values than SRS-50. In conclusion, compared with the 'at convenience' nuclear sampling method, systematic random sampling of nuclei is not only superior with respect to reproducibility of results, but also provides a better prognostic value in patients with invasive breast cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7579507     DOI: 10.1007/BF00690185

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients.

Authors:  P J van Diest; J P Baak
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

2.  Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

Authors:  A M Uyterlinde; N W Schipper; J P Baak
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

3.  The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients.

Authors:  J C van der Linden; J Lindeman; J P Baak; C J Meijer; C J Herman
Journal:  Cytometry       Date:  1989-01

4.  Adjuvant CMF chemotherapy in operable breast cancer: ten years later.

Authors:  G Bonadonna; A Rossi; P Valagussa
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

5.  Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up.

Authors:  A M Uyterlinde; J P Baak; N W Schipper; H Peterse; E Matze; C J Meijer
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

6.  Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.

Authors:  J C van der Linden; J P Baak; J Lindeman; J Hermans; C J Meyer
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

7.  Prognostic indicators in breast cancer--morphometric methods.

Authors:  J P Baak; P H Kurver; A J De Snoo-Niewlaat; S De Graef; B Makkink; M E Boon
Journal:  Histopathology       Date:  1982-05       Impact factor: 5.087

8.  Nuclear feulgen DNA content and nuclear size in human breast carcinoma.

Authors:  S D Fosså; P F Marton; O S Knudsen; O Kaalhus; O Børmer; S Vaage
Journal:  Hum Pathol       Date:  1982-07       Impact factor: 3.466

9.  The value of morphometry to classic prognosticators in breast cancer.

Authors:  J P Baak; H Van Dop; P H Kurver; J Hermans
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

10.  Reproducibility of mean nuclear volume and correlation with mean nuclear area in breast cancer: an investigation of various sampling schemes.

Authors:  J P Baak; M Ladekarl; F B Sørensen
Journal:  Hum Pathol       Date:  1994-01       Impact factor: 3.466

View more
  5 in total

1.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

Authors:  P J van Diest; R J Michalides; L Jannink; P van der Valk; H L Peterse; J S de Jong; C J Meijer; J P Baak
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.

Authors:  M Sisto; L Lorusso; R Tamma; G Ingravallo; D Ribatti; S Lisi
Journal:  Clin Exp Immunol       Date:  2019-06-05       Impact factor: 4.330

3.  Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases.

Authors:  M J Edel; J M Harvey; J M Papadimitriou
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Reduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.

Authors:  Margherita Sisto; Loredana Lorusso; Giuseppe Ingravallo; Roberto Tamma; Beatrice Nico; Domenico Ribatti; Simona Ruggieri; Sabrina Lisi
Journal:  J Mol Histol       Date:  2018-01-04       Impact factor: 2.611

5.  Automatic nuclei segmentation in H&E stained breast cancer histopathology images.

Authors:  Mitko Veta; Paul J van Diest; Robert Kornegoor; André Huisman; Max A Viergever; Josien P W Pluim
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.